Editing Cencora (section)

==Distribution of Remdesivir==
In June 2020, the [[United States Department of Health and Human Services|U.S. Department of Health and Human Services (HHS)]] announced an unusual agreement for the distribution of [[remdesivir]], the first coronavirus drug. HHS agreed to manufacturer [[Gilead Sciences |Gilead]]'s [[Wholesale acquisition cost|wholesale acquisition price]], while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.<ref name="Kolata">{{cite news |last1=Kolata |first1=Gina | name-list-style = vanc |title=Remdesivir, the First Coronavirus Drug, Gets a Price Tag |url=https://www.nytimes.com/2020/06/29/health/coronavirus-remdesivir-gilead.html |work=[[The New York Times]] |date=29 June 2020 |access-date=29 June 2020}}</ref><ref name="HHSPressRelease_29June2020">{{cite press release |title=Trump Administration Secures New Supplies of Remdesivir for the United States |url=https://www.hhs.gov/about/news/2020/06/29/trump-administration-secures-new-supplies-remdesivir-united-states.html |publisher=[[U.S. Department of Health and Human Services]] (HHS) |date=29 June 2020 |access-date=29 June 2020 |archive-date=June 29, 2020 |archive-url=https://web.archive.org/web/20200629144040/https://www.hhs.gov/about/news/2020/06/29/trump-administration-secures-new-supplies-remdesivir-united-states.html |url-status=dead }}</ref>